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Abstract Sequence homology between the a-subunits of G-pro- 
teins and other GTP-binding proteins and certain regions within 
the nueleotide binding domains (NBDs) of cystic fibrosis trans- 
membrane conductance regulator (CFTR) indicates that these 
protein structures may be similar. A sequence alignment of the 
NBDs of CFTR and NBDs from other membrane transporters, 
forms the basis of a structural model. This model predicts that 
one of the conserved sequences GGQR, within which a number 
of CF mutations occur, forms part of the nueleotide binding 
pocket and serves as an ON/OFF conformational switch as ob- 
served in GTP binding proteins. Furthermore, based on subtle 
sequence differences between the first and second NBDs of CFTR 
and from structure-activity data, we suggest hat the nueleotide 
binding site environments of the two NBDs are different. 
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of two NBDs in CFTR also raises the question whether the 
domains are functionally different. Regarding signal transmis- 
sion, Ames and Lecar [8] recently proposed that the conserved 
region (GGQR) is located some distance from the nucleotide 
binding pocket and acts as a linker region in transmitting sig- 
nals from the nucleotide binding pocket o other domains of the 
protein. However, we note that the sequence motif GGQR is 
observed in O-related proteins as an integral portion of the 
nucleotide binding pocket [9]. Our sequence comparison of the 
NBDs of transport related proteins with other ATP- and GTP- 
binding proteins has revealed a remarkable l vel of sequence 
conservation between NBDs and G-related proteins [10,11] in 
certain regions. In this minireview we summarize the sequence 
and structural similarities between the NBDs of CFTR and 
G-related proteins and present an alternative model for the 
NBD regions of CFTR. We also characterize the functional 
regions involved in conformational switching and discuss their 
roles in signaling mechanism. 
1. Introduction 
Cystic fibrosis transmembrane conductance regulator 
(CFTR) is a membrane protein and functions as a chloride 
channel regulated by both protein kinase A mediated 
phosporylation and binding of ATP [1]. Mutations in the gene 
coding CFTR causes cystic fibrosis (CF), a common lethal 
genetic disease characterized by the defective pithelial chloride 
transport [2]. CFTR belongs to a superfamily of transport re- 
lated proteins [3] that include multiple drug resistance glycopro- 
tein (MDR), 0~-factor pheromone export system (STE6), MHC- 
linked peptide transporter system (HAM 1, RING4, etc.) hemo- 
lysin and a number of periplasmic permeases (HisP, MalB, 
etc.). These transporter proteins, in addition to having a mem- 
brane associated component as a common structural element, 
share one or more ATPInucleotide binding domains (NBD). 
Hyde et al. [4] proposed a model of the NBD of CFTR based 
on a comparison with the crystal structure of another ATP 
binding protein, adenylate kinase (ADK) [5]. Mimura et al. [6] 
modeled the NBD of another transport related protein, His P. 
The latter model was based on the three dimensional structures 
of both ATP- and GTP- binding proteins. 
Although there is evidence indicating that hydrolysis of ATP 
is required for the channel activity of CFTR [7], it is not clear 
how hydrolysis is involved in signal transduction. The presence 
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2. Sequence comparisons between CFTR and other 
transport-related molecules and G-proteins 
The sequence alignment shows four sequence motifs shared 
by the NBDs of transport related proteins and GTP binding 
proteins (Fig. I). The first region contains the Walker A se- 
quence (GXXXXGKS/T) which is characteristic ofmany ATP- 
and GTP-binding proteins and is also observed in CFTR and 
G-related proteins. This region is often called the P-loop or 
loop LI (loop LI in Fig. 1). The second conserved sequence has 
the motif G-G-Q-/R/K/Q and is labeled loop LA in Fig. I. This 
motif has been defined as switch II region for transducin-0~ [I 2]. 
The motifGGQR which is found in all O-proteins including the 
ADP-ribosylating factor family, is also conserved in CFTR and 
other transport related proteins, but surprisingly its conserva- 
tion between G-proteins and ATP-dependent transporters has 
not been noted previously. However, this sequence motif is not 
obvious in the other ATP and GTP binding proteins (although 
the GQ of ras p21 is readily aligned; Fig. 1). 
The third conserved sequence isthe Walker B motit; contain- 
ing four hydrophobic amino acids followed by D/E, character- 
istic of many ATP-binding proteins. Walker B is also observed 
in CFTR, ADK and other transporters included in this class. 
G-Proteins and GTP-binding proteins ras p21 and EF-Tu have 
the hydrophobic stretch of the Walker B motif but they do not 
have the negatively charged residue at the C.terminal end. In- 
terestingly, GK which is highly homologous to ADK also does 
not have the charged residue at the C.terminal end. On the 
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other hand, the ADP-ribosylation factor family (ARL2) has the 
Walker B motif including the charged residue (Fig. 1). A fourth 
conserved motif AXSAXD immediately after the Walker B 
sequence was also noted shared between by the G proteins and 
certain membrane transporters uch as MDR, STE6 but this 
motif is not apparent in CFTR. 
Another important sequence pattern that is conserved in all 
G-proteins is the motif R-X-X-T. This motif which is located 
23 residues up-stream from the GGQR motif has been called 
switch I region (Fig. 1) for transducin-¢z [12] and is involved in 
binding to GTP. In NBDI of CFTR, switch I role may be 
played by Arg-487 (Fig. 1). Alternatively, the motif R-X-X-S 
(516-$19, not shown in Fig. l) found 33 residues up stream 
from GGQR motif may perform this role. However, this motif 
is not conserved in all of these transport proteins. 
3, Topotoilical odentntions of functional reuions in G-proteins 
and CFTR 
The three-dimensional structure of NBDs are most likely 
composed of a core parallel ,0-sheet structure surrounded by 
~-helices. The prediction of this core structure involves consid- 
eration of the number of ,&strands, their location along the 
sequence and their ordering and orientation in three-dimen- 
sional space. 
G-proteins are homologous to GTP-binding ras 1)21 and 
EF-Tu in that they all share three functionally important se- 
quence motifs (GXGXXGK, DXXG and NXXD)  which have 
been shown to be involved in the regulation of GTP/GDP 
binding and hydrolysis [11]. This predicts that the core,~-sheet 
structure of the major nucleotide binding regions of G-proteins 
are likely to have a structure similar to ras p21 or EF-Tu. This 
is confirmed by inspection of the tertiary structure of 1)21, 
EF-Tu and the G protein transducin-0~ asdetermined by X-ray 
crystallography [12]. The locations of these ,~-strands for G- 
proteins based on the crystal structure of transducin-0~ are 
shown in Fig. 1. Accordingly, loop LI, which has the conserved 
Walker A GXGXXGK motif would follow,~-stand A and loop 
1.4 which includes the DXXG and the overlapping GGQ/R/KJ 
Q motifs defined here would connect ~-stand C and ~-strand 
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Fig, I, Sequence alignment between the nucl~tide binding regions of G-proteins and nlembrane associated transporters. Amino acid sequences of 
CFTR from human, mouse and dogfish, MDR, 5TE6, Haml, His P and HlyB were considered in this analysis. In the case of MDR, STE6 and CFTR 
both N- and C-terminal NBD domains were considered, The ATP-binding proteins, adenylate kinase (ADK) and guanylate kinase (GK) were included 
along with the GTP-binding proteins ras p21, EF-To factor and the 0~-subunit of several G-proteins. All the sequences were aligned using the WCG 
program BEUTFIT with gap penalty 3 and were manually adjusted to maximize the homology. Highly conserved residues hared by transporter NBDs 
and G-proteins are in bold, The locations of,B-strands observed in the crystal structure for ras p21, EF-Tu, transducin-~, ADK and GK are shown 
as broken lines below their respective sequences. The locations of~-strands for G-proteins would correspond to the same regions observed for ras 
p2 i, ,~ is antiparallel for Ras and Eftu, whereas it is parallel for ADK and GK. The regions that have the potential of forming,~-strands in transport 
NBDs are shown by solid lines above the sequences, ,0~, fib, ,Be, etc. denote ,&strand assignments. ,0.strand B for CFTR is predicted to be parallel. 
CFhN, MDmN, $t6N = N-terminal NBD domains ofCFTR, MDR and 5TE6, respectively; CFhC, MDmC, STUC = C-terminal NBD domains of 
CFTR, MDR and UTE6, respectively; CFhN, CFhC from human; CFmN, CFmC, MDmN, MDmC from mouse; CFdN, CFdC from dogfish; His 
P, histidine permease; HAM I, MHC-linked peptide transporter, G~, G~, Go denote G-related protein subunits; Tt, transducin GTP binding subunit; 
see Riordan et al, [I], Bourne et al, [I !] and Manavalan et al. [27] for references; ARL2, ADP-ribosylation factor-like protein [28]; ADK, adenylate 
kinase; GK, guanylate kinase, Broken lines and dots within the sequence denote gaps and missing segments, respectively. 
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Fig. 2. A schematic representation showing ,0-strands A, C and D and the mutational sites in the connecting loops LI and L4 which are involved 
in phosphate binding. Shaded bars represont p-strands. (A) Model for ras p21, EF-Tu and G-proteins (adapted from Psi et al. [20]. The residues 
shown in the loops correspond to ras. The mutations are: LI: GI2 .-, V,D; L4:G60 -~ L; Q61 -, L. (B) Model for transport NBDs. The residues 
and the mutations correspond to CFTR. The mutations are: LI: G458 --, V; L4:5549 -~ I,R; G551 -, D; A559 ~ T; Y563 --, N. 
D. Sequence homology between G-proteins and NBDs in both 
loop LI and loop L4 regions would strongly suggest that NBDs 
would also have p-strand A//-strand C,//-strand D and p- 
strand E at similar locations. These four regions are labelled 
strand A, strand C, strand D and strand E, respectively in Fig. 
1. The assignment of these four p-stands are in agreement with 
the prediction made by Hyde et al. [4]. 
The crystal structures of EF-Tu, ras p21 and transducin-~ 
complexed with GTP and GDP indicate that critical residues 
involved in binding to GTP/GDP are located in loop L1 and 
loop L4 regions. Based on our prediction, we propose that the 
same loops also form the nucleotide binding sites for CFTR 
and other transporters in this class. This model would place the 
loop L4 in juxtaposition to loop L I (Fig. 2) where it can directly 
interact with bound nucleotide. This is in contrast to the model 
proposed by Ames and Lecar [8]. According to their model, 
loop L4 region does not interact with loop LI and is located 
distantly from the nueleotide binding site. 
4. Structure-activity data 
There are a number of mutations in the NBDs of CFTR that 
cause CF or impair the biological function of CFTR [13-14]. 
There is a high incidence of missense mutations within the 
N-terminal NBD and they are clustered essentially in three 
major locations. The first mutation region is in the vicinity of 
the Walker A motif(loop LI, Fig. 1). It is well documented that 
both for ATP and GTP binding proteins this region is critical 
and is involved in binding the phosphate moieties of a nucleo- 
tide. More specifically, the invariant Lys/Arg residue in loop L I 
is involved in binding to cz and p phosphates while the adjacent 
Ser/Thr esidue interacts with Mg z+ ion. Table I depicts pecific 
residues that are likely to interact with nucleotides for different 
ATP/GTP binding proteins. Table 1 also includes the putative 
nucleotide binding site residues from NBDI and NBD2 of 
CFTR. Consistent with their playing a major role in protein 
function, mutation at most of these sites causes CF or affects 
the channel activity of CFTR. 
The second region associated with CF mutations is in the 
vicinity of Phe-508 and the homology for this region with any 
other protein is not apparent. The third mutation region pre- 
cedes the Walker B motif. According to our structural predic- 
tion, this latter egion is in the loop L4 that connects ,0-strand 
C and p-strand D of CFTR as seen in G-proteins (Fig. l). 
Mutations in this region also drastically affect the catalytic 
activity of GTP/ATP binding proteins. For example, the car- 
boxylate group of aspartic acid or a hydroxyl group of Ser/Thr 
in loop L4 is involved in coordinating Mg 2+ ion in GTP binding 
proteins. The corresponding residue for CFTR may be Thr-547 
or Ser-549 (Glu-543 is also close to this region). 
Interestingly, the residues in the loop L4 region (the so-called 
'switch II' region) have also been shown to be critical for the 
proper functioning of GTP-binding proteins [9,11,12,15]. The 
loop L4 which interacts with the phosphoryl binding loop L I 
has been shown to play a role in switching the protein from its 
GDP bound to its GTP bound conformation (Fig. 2A). The 
substitution of Leu for the most conserved residue Gin at this 
site significantly reduces the catalytic activity of Gs~(Gln- 
227 - ,  Leu) as well as ras p21 (Gln-61 -) Leu). Similarly, the 
substitution of Ala for Gly in the adjacent residues (Gly- 
226 -~ Ala for Gs~ and Gly-60 - ,  Ala for Ras p21) substantially 
reduces the flexibility of L4, and thereby prevents the signal 
transmission i itiated by binding GTP. CF related mutations 
have also been observed at the equivalent site where Gly has 
been replaced by Asp in both the NBDs (Gly-551 ---* Asp and 
Giy-1349 -o Asp) of CFTR (Fig. 2B). The corresponding STE6 
missense mutations also result in dramatically reduced STE6 
function [16]. Other mutations in this region that are associated 
with CF are Ser-549 ~ lie, or Arg or Asn and Ala-559 -~ Thr 
[13,14,17]. This consistency in the structure-activity data 
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between NBDs and ras p21 and G-proteins would strongly 
suggest that the orientation of this loop as well as the assign- 
menUs of,0-strand C and p-strand D are similar for both trans- 
port-NBDs and GTP binding proteins. 
~;. Catalytic roles of switch ! and switch !1 regions 
The involvement of switch I and switch II regions in binding 
to the 7' phosphate ofGTP and in catalytic activity is more clear 
from the crystal structures of G~-protein complexed with GDP 
[12] and GTP7'S [18]. Crystal structure of Gtc,-GTPTS shows 
that the structural changes in the switch I region are induced 
by hydrogen bonds between the 7'-phosphate of GTP and Thr- 
177 and to a lesser extent with Arg-174 (switch I region). 
r~hange s in the switch II region are initiated by a hydrogen 
bond between Gly-199 and the 7'-phosphate of GTP. More 
recently, Coleman et al, [19] determined the crystal structures 
of Gtal protein complexed with GTPT'S and GDP-ALF4 and 
showed specific roles of Arg-178 and Gin-204 in transition state 
stabilization. Gin.204 of Gi, t protein (Gin-61 in ras p21; [20]) 
stabilizes and orients the hydrolytic water molecules to the 
tdgonal 7'-phosphate in the transition state and Arg.178 pro- 
motes bond cleavage by stabilizing the developing negative 
charge in the oxygen atoms of the 7'-phosphate. 
Based on the structure-activity data and homologies in 
switch I and switch I1 regions, we suggest that these regions in 
CFTR play a similar ole in ATP binding and hydrolysis. More 
specifically, Gin-552 in switch II region and Arg-516 in switch 
I region (or Arg-487) may be involved in transition state stabi- 
lization. Gly-551 may interact with the y-phosphate of ATP. 
The presence of all these critical residues in NBDI together 
with the recent report [21] that a Gin residue at a similar loca- 
tion in the ATP hydrolyzing RecA protein may be critical for 
the binding of ATP leads us to suggest that NBD! may indeed 
hydrolyze ATP. 
6, Functional roles of the NBDs I. the activation of CFTR 
While the two NBDs in CFTR have very similar sequences 
and equivalent Walker A and B motifs, other key residues 
involved in transition state stabilization and catalytic activity 
are different, suggesting different functional roles for the 
NBDs. The R-X-X-T sequence (switch 1), which is important 
in both ribose and ~. and 7'-phosphate coordination in 
transducin.a, is present in NBDI but not in NBD2. The GGQR 
sequence (switch II) of NBDI is consistent with the consensus 
motif GGQ/R/K/Q, but in NBD2 the corresponding sequence 
is HGHK. The region around ,#-strand B, which is involved in 
binding to nucleotides in many ATP/GTP binding proteins 
[5,11] is also different for the two NBDs (Fig. 1). In NBD1, the 
sequence around//-strand B is KIKHSGR (481-487) and in 
NBD2 the corresponding sequence is EIQIDGV (1266--1272). 
The absence of Gin and other key residue in NBD2 suggests 
that the binding affinity of ATPIADP or the rate of ATP hy- 
drolysis at NBD2 may be different from NBDI. Alternatively, 
ATP hydrolysis may only occur in NBD1 and NBD2 may have 
a role in nucleotide xchange related especially to ADP, 
Structure-activity data from two laboratories [22,23] are 
consistent with such complementary oles for the NBDs of 
CFTR. These two studies reported mutated residues at similar 
locations in each NBD and measured the channel activity of 
CFTR. The structure-activity analysis indicates that mutation 
in the LI region of the first NBD (K464 to M, Q, A, R) 
drastically reduced the chloride channel activity, whereas the 
equivalent mutation in NBD2 (K 1250) enhanced chloride chan- 
nel activity by abolishing the inhibitory effect of ADP on chlo- 
ride conductance [22]. Similar effects on chloride current and 
ADP inhibition were observed when D572 and D1370 were 
mutated to Asn. Smit et al. [23] also found opposing effects in 
the activation of CFTR chloride channel by 3-isobutyl.l.meth. 
ylxanthine (IBMX) when the similar homologous NBDI and 
NBD2 mutations were introduced. The NBDI mutations 
(K464Q, D572N) showed a decrease in sensitivity to IBMX 
activation while the equivalent NBD2 mutations (KI250Q, 
DI370N) produced an increase in IBMX sensitivity, These re- 
sults together with our sequence analysis data suggest that the 
nature of nuclcotide binding and the subsequent conforma- 
tior~:,l changes may differ for the two domains. 
7. Nueleotide regulated molecular switch for signal transductlen 
G- or GTP-binding proteins function as a molecular switch 
that regulates the opening and closing of signal transduction. 
All signal transducing GTP-binding proteins bind and hydro- 
lyze GTP, properties which are crucial to their function as a 
molecular switch [11]. The GTP-bound form is the active con- 
formation and turns on the signal and the hydrolysis of GTP 
to GDP bound form shifts the conformation to an inactive 
form, i.e. turns off signal transduction. 
The signal transduction mechanism is more complex in 
CFTR because of the presence of two NBDs. Based on the 
chloride channel activity data, Gunderson and Kopito [24] pro- 
posed that binding of ATP at both NBDI and NBD2 of CFTR 
is required to open the channel and ATP hydrolysis at at least 
one of these sites is necessary for transition to the closed state. 
Furthermore, they also demonstrated that orthovandate, a 
transition state analog, and poorly hydrolyzable ATP analogs 
do not open the channel but in the presence of ATP they all 
Table I
Residues interacting with phosphate moieties and Mg'* ion in GTP/ATP binding proteins and the potential sites in CFTR 
Protein Phosphate moiety Mg 2+ ion 
H-ras 21 GIS, AI8 VI4, GIS, Ki6, Si7 GI3, T35, G60 
EF-Tu G23, T26, Y47 G23, K24, T25 K24, T62, G84, H85 
Transducin ~ T44, RI74 G41, K42, $43, TI77 E39, K42, R174, T177, G199 
Re¢ A T73 K72, T73 K72, E96, QI94 
CFTR NBDI G463, R516 G463, K464, "!"465, $466 K464, R487, $549, G551, Q552, 
R516, $519 
K1250, S1347, G1349 
S17, T35, D33, D57 thru H~O 
T25, T62, D51, D80 thru H20 
CFTR NBD2 G1249 G!249, K1250, S1251, T1252 
$43, T177, $43, T177 D196 thro H20 
T73, E96, DI44 
$485, T547, $549, E543, D572 
D1270, S1347, D1370 
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lead to prolonged opening of the channel. However, they could 
not establish from their data whether ATP hydrolysis is re- 
quired for channel opening because analogs and polyphosphate 
compounds do not appear to compete with ATP for the open- 
ing transition. Hwang et al. [25] studied the channel activity of 
CFTR and came to the conclusion that ATP hydrolysis at 
NBDI controls channel opening and ATP hydrolysis at NBD2 
regulates channel closing. 
The proposed regulatory model for NBD2 is analogous to 
the switching mechanism proposed for GTP binding proteins. 
By analogy with the mechanism of GTP hydrolysis of ras p21, 
EF-Tu and G-proteins, the ATP bound form in NBD2 might 
be the active conformation that turns on the transmission signal 
(and/or keeps the channel open) and the hydrolysis of ATP to 
bound ADP may shift the conformation to an inactive form, 
i.e. to turn off the signal transduction or close the channel. 
Alternatively, the overall mechanism could be, as with GTP- 
binding proteins, that NBDI is the primary activation switch 
and NBD2 acts to exchange out the ADP to recycle the switch 
for ATP activation. Subsequent exchange of ADP off of NBD2 
could require competitive binding by the high, physiological 
levels of ATP [26] often necessary for CFTR channel activa- 
tion. 
8. Conclusions 
The structural similarities between G-proteins and the NBDs 
of CFTR addressed in this review may prove to be useful in 
understanding the regulatory role of NBDs in opening and 
closing the CFTR chloride channel. It is clear from the se- 
quence homology and structure-activity data that the confor- 
mational changes in switch I and switch II regions are critical 
for regulating the ON/OFF switching mechanism. Structure- 
activity data also indicates that the functional roles of the 
NBDs are different, a difference that our structural modeling 
suggests may relate to hydrolysis-dependent molecular switch- 
ing versus nucleotide xchange recycling and perhaps ATP/ 
ADP ratio sensing. Though ADP bound to NBD2 appears to 
close the CFTR channel, more data is necessary to confirm that 
the bound ADP actually comes from the hydrolysis of ATP at 
NBD2. 
It will also be interesting to investigate by specific mutations 
whether the NBDs of CFTR can be locked in a conformation 
that would favor the opening state of the CFTR channel. Since 
the natural, CF related mutations in L1 and L4 regions of 
CFTR have only been found to have decreased or no channel 
activity, their impact on this mechanism should only be nega- 
tive in contrast o the well-known mutations of GTP-binding 
proteins which favor the active or open state of the switch, e.g. 
the oncogenic mutation of Giy-12 to Val or Asp in ras p21 [9]. 
Specific mutations in the functional regions outlined here and 
subsequent structure-activity analysis may lead to a better 
understanding of the relationship between ATP binding/hy- 
drolysis and CFTR channel activity. 
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